Cellular senescence appears to be an important part of organismal aging. Ce
llular senescence is characterized by flattened enlarged morphology, inhibi
tion of DNA replication in response to growth factors, inability to phospho
rylate the pRb tumor suppressor protein, inability to produce c-fos or AP-1
and overexpression of a variety of genes, notably p21 (CIP-1/WAF-1) and p1
6(INK). It is now clear that certain early mitotic signals become defective
with the onset of senescence. Among these is the PLD/PKC pathway. Evidence
suggests that activation of PLD and PKC is critical for mitogenesis. Recen
t data suggest that the defect in PLD/PKC in cellular senescence is a resul
t of elevated cellular ceramide levels which inhibit PLD activation. It app
ears that the elevated ceramide is a result of neutral sphingomyelinase act
ivation. Ceramide acts to inhibit the activation of PLD by possibly three m
echanisms, inhibiting activation by Rho, translocation to the membrane and
gene expression. Addition of ceramide to young cells not only inhibits PLD
but also recapitulates all the standard measures of cellular senescence as
described above. (C) 1999 Elsevier Science B.V. All rights reserved.